申请人:Nikken Chemicals Company, Limited
公开号:EP0816366A1
公开(公告)日:1998-01-07
An imidazothiazole compound having the formula (A):
wherein R1 is a phenyl or napthyl which may have a substituent, R2 is an acyl, and the two bonds at dotted line portions may or may not exist simultaneously, or a pharmacologically acceptable salt thereof and an agent for overcoming resistance to an anti-neoplastic agent or an enhancer for the effect of an anti-neoplastic agent comprising said compound or a pharmacologically acceptable salt thereof as an active ingredient.
一种咪唑噻唑化合物,其式为(A):
其中 R1 是苯基或萘基,可以有取代基,R2 是酰基,虚线部分的两个键可以同时存在,也可以不存在,或其药理上可接受的盐,以及一种用于克服抗肿瘤药物抗药性的制剂或一种抗肿瘤药物效果增强剂,其活性成分包括上述化合物或其药理上可接受的盐。